Video
Dr. Kuerer on De-Escalating Surgery in the Treatment of Patients With Breast Cancer
Author(s):
Henry M. Kuerer, MD, PhD, professor of Surgery, PH and Fay Etta Robinson Distinguished Professor in Research, Breast Surgical Oncology, executive director, Breast Programs, director, Breast Surgical Oncology Fellowship Training Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses de-escalating surgery in the treatment of patients with breast cancer.
Henry M. Kuerer, MD, PhD, professor of Surgery, PH and Fay Etta Robinson Distinguished Professor in Research, Breast Surgical Oncology, executive director, Breast Programs, director, Breast Surgical Oncology Fellowship Training Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses de-escalating surgery in the treatment of patients with breast cancer.
Kuerer believes this research has the potential to be significantly transformative, as women with invasive breast cancer may be able to completely avoid surgery as they undergo treatment.
He goes on to discuss the Feasibility Trial1, which is currently looking to see if oncologists can predict which patients will have no residual disease without breast surgery. As of now, the trial has sustained outstanding results, and these preliminary analyses will contribute to future lines of research in this area.
Reference
1. Kuerer HM. MD Anderson Cancer Center Feasibility Trial for Eliminating Breast Cancer Surgery in Exceptional Responders. Paper presented at: 15th Annual International Congress on the Future of Breast Cancer; July 22, 2016; New York, NY.
